GIPICA Trademark

Trademark Overview


On Wednesday, January 13, 2021, a trademark application was filed for GIPICA with the United States Patent and Trademark Office. The USPTO has given the GIPICA trademark a serial number of 90463328. The federal status of this trademark filing is REGISTERED as of Tuesday, August 30, 2022. This trademark is owned by Eutilex Co., Ltd.. The GIPICA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment of cancer cells; Cells for medical or clinical use; Pharmaceutical preparations for activating cellular function; Biological preparations for the treatment of immune system related disorders; Biological preparations for the treatment of cancer; Pharmaceutical preparations for immunity adjustment; Pharmaceutical preparations for regulating the immune system; Pharmaceutical preparations for tumor treatment; Vaccines; Pharmaceutical preparations for the treatment of cancers with T cells; Pharmaceutical preparations for the treatment of cancers with CAR-T cells

Product development in the field of cell therapy; biomedical research services; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; product development, namely, biologics development; biological research and analysis; consultancy in the field of analysis of biology sequence processing for medical research purposes; multiple nucleotide sequence analysis for scientific research purposes; DNA sequence analysis for scientific research purposes; medical research services in the field of cell separation; medical research in the field of biologics
gipica

General Information


Serial Number90463328
Word MarkGIPICA
Filing DateWednesday, January 13, 2021
Status700 - REGISTERED
Status DateTuesday, August 30, 2022
Registration Number6834837
Registration DateTuesday, August 30, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 1, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cancer cells; Cells for medical or clinical use; Pharmaceutical preparations for activating cellular function; Biological preparations for the treatment of immune system related disorders; Biological preparations for the treatment of cancer; Pharmaceutical preparations for immunity adjustment; Pharmaceutical preparations for regulating the immune system; Pharmaceutical preparations for tumor treatment; Vaccines; Pharmaceutical preparations for the treatment of cancers with T cells; Pharmaceutical preparations for the treatment of cancers with CAR-T cells
Goods and ServicesProduct development in the field of cell therapy; biomedical research services; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; product development, namely, biologics development; biological research and analysis; consultancy in the field of analysis of biology sequence processing for medical research purposes; multiple nucleotide sequence analysis for scientific research purposes; DNA sequence analysis for scientific research purposes; medical research services in the field of cell separation; medical research in the field of biologics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 13, 2021
Primary Code005
First Use Anywhere DateThursday, January 7, 2021
First Use In Commerce DateWednesday, April 27, 2022

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 13, 2021
Primary Code042
First Use Anywhere DateFriday, January 7, 2022
First Use In Commerce DateWednesday, April 27, 2022

Trademark Owner History


Party NameEutilex Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSeoul 08591
KR

Party NameEutilex Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeoul 08591
KR

Party NameEutilex Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeoul 08591
KR

Trademark Events


Event DateEvent Description
Tuesday, August 30, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 30, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, July 26, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, July 25, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, July 11, 2022STATEMENT OF USE PROCESSING COMPLETE
Tuesday, June 14, 2022USE AMENDMENT FILED
Tuesday, July 5, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 14, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, April 26, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 1, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 1, 2022PUBLISHED FOR OPPOSITION
Wednesday, February 9, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 24, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 21, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 21, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 21, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 19, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, August 19, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 19, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, July 23, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 23, 2021NON-FINAL ACTION E-MAILED
Friday, July 23, 2021NON-FINAL ACTION WRITTEN
Friday, July 23, 2021ASSIGNED TO EXAMINER
Tuesday, April 13, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, January 16, 2021NEW APPLICATION ENTERED IN TRAM